DBV Technologies S.A. ADR Company Profile
NASDAQ: DBVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
9.77-0.21 (-2.10%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
DBV Technologies S.A. at a glance
DBV Technologies S.A. ADR (NASDAQ: DBVT) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2014. At a market capitalization of $614.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001613780, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- DBV Technologies S.A. ADR
- Ticker
- NASDAQ: DBVT
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- France
- IPO year
- 2014
- Market cap
- $614.03M
- SEC CIK
- 0001613780
Companies similar to DBV Technologies S.A.
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PROKProKidney Corp. Class A | 1.57 | -1.88% | $626.72M | vs DBVT |
| ETRAElectra Therapeutics Inc. | 9.16 | -6.72% | $574.95M | vs DBVT |
| AURAAura Biosciences Inc. | 6.46 | +4.70% | $669.93M | vs DBVT |
| VALNValneva SE ADR | 5.87 | +0.17% | $556.61M | vs DBVT |
| FDMT4D Molecular Therapeutics Inc. | 12.59 | +0.24% | $695.52M | vs DBVT |
| PRMEPrime Medicine Inc. | 3.90 | +11.43% | $707.37M | vs DBVT |
| RGNXREGENXBIO Inc. | 7.60 | +1.95% | $501.37M | vs DBVT |
| ALLOAllogene Therapeutics Inc. | 1.43 | -2.05% | $494.05M | vs DBVT |